CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-07-24). The draft was written by AI, the existence of all 2 cited sources was verified at the original page, and the verdict passed blind grading and adversarial audit. Methodology v0.6.
Verdict No. 1698 · Search date 2026-07-24 · Methodology v0.6

Single-dose oral dexamethasone,
does it really help with Complete resolution of acute sore throat within 24 hours without antibiotics?

30-Second Summary
D
Evidence Grade D · 34 · Safety caution
The 24-hour complete-resolution primary endpoint failed, while improvement at 48 hours was secondary
What the
research shows
A single dexamethasone dose is rated D because the primary endpoint failed. Hayward 2017 randomized 576 participants and analyzed 565 after excluding 11 later found ineligible. Complete resolution at 24 hours was 22.6% versus 17.7%, RR 1.28 (95% CI 0.92 to 1.78), P=.14. The 48-hour result of 35.4% versus 27.1%, P=.03, was a prespecified secondary endpoint.
What the
ads claim
Marketing can transform 48-hour or antibiotic-adjunct evidence into a claim of standalone cure within one day.
*

Useful facts when choosing a product

  • TOAST evaluated one 10-mg oral dexamethasone dose.
  • Participants were adults in primary care who did not require immediate antibiotics.
Gap Measurement · Verdict 1698 · D 34
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

Hayward 2017 randomized 576 participants and analyzed 565 after excluding 11 found ineligible: 288 dexamethasone and 277 placebo. The 24-hour complete-resolution primary endpoint failed at 22.6% versus 17.7%, RR 1.28 (95% CI 0.92 to 1.78), P=.14. Complete resolution at 48 hours was 35.4% versus 27.1%, P=.03, but it was a prespecified secondary endpoint.

02

Why this is classified as D (34)

The direct 24-hour primary endpoint failed, the 48-hour result was secondary, and synthesis evidence was mainly adjunctive to antibiotics, yielding D with 34 points.

Counterpoint. Possible short-term adjunctive benefit for severe swallowing pain does not justify repeated or self-directed use.

Rejudgment record. Cross-check applied — Applied rule ①-ⓑ because the 24-hour complete-resolution primary endpoint without immediate antibiotics failed and was not upgraded by a positive 48-hour secondary endpoint or mostly antibiotic-adjunct synthesis evidence

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Complete sore-throat resolution within 24 hours without immediate antibioticsDThe direct primary endpoint failed with P=.14.
Complete sore-throat resolution within 48 hours without immediate antibioticsCThe result was positive but was a prespecified secondary endpoint from one confirmatory trial.
Complete sore-throat resolution within 24 hours when added to antibioticsCThe pooled effect was positive, but trials were small and heterogeneous.

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Hayward GN et al. 2017Multicenter double-blind placebo-controlled randomized trial277Public funding from the United Kingdom NIHR School for Primary Care Research; sponsor had no role in conduct or analysisPrimary endpoint of patient-reported complete sore-throat resolution at 24 hoursPrimary endpoint failed: 22.6% versus 17.7%, RR 1.28 (95% CI 0.92 to 1.78), P=.14. The 48-hour result of 35.4% versus 27.1%, P=.03, was a prespecified secondary endpoint.Pivotal negative trial directly matching the claim
de Cassan S et al. 2020 Cochrane reviewSystematic review of randomized trials8Only two included trials reported funding, from government and a university foundation; others did not report itComplete pain resolution at 24 and 48 hoursThe 24-hour RR was positive at 2.40, but the evidence was mostly adjunctive to antibiotics and indirect for standalone treatment.Positive synthesis with limited directness
§

Receipt — 2 References

All 2 cited sources were verified for existence at the original page (as of 2026-07-24).

Hayward GN, Hay AD, Moore MV, et al. Effect of Oral Dexamethasone Without Immediate Antibiotics vs Placebo on Acute Sore Throat in Adults: A Randomized Clinical Trial. JAMA. 2017;317(15):1535-1543. DOI: 10.1001/jama.2017.3417.
checked
de Cassan S, Thompson MJ, Perera R, et al. Corticosteroids as standalone or add-on treatment for sore throat. Cochrane Database Syst Rev. 2020;2020(5):CD008268. DOI: 10.1002/14651858.CD008268.pub3.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-07-24 · Corrections: none

Cite this verdict

Single-dose oral dexamethasone x complete sore-throat resolution within 24 hours Evidence Grade D card
[Chamgap] Single-dose oral dexamethasone x complete sore-throat resolution within 24 hours — Evidence Grade D·34. 2 cited sources checked. Source: https://chamgap.com/en/verdicts/immunity/single-dose-oral-dexamethasone-sore-throat-24h-without-antibiotics/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.